Deafness-epiphyseal dysplasia-short stature syndrome

Deafness-epiphyseal dysplasia-short stature syndrome, also known as Deafness-small joint osteoarthritis syndrome or DED-short stature syndrome, is an extremely rare genetic disorder characterized by the combination of sensorineural hearing loss, epiphyseal dysplasia (abnormal development of the growing ends of bones), and short stature. The condition primarily affects the skeletal system and the auditory system. Affected individuals typically present in childhood with progressive sensorineural deafness, disproportionately short stature, and skeletal abnormalities including epiphyseal changes that can lead to early-onset osteoarthritis, particularly affecting the small joints of the hands and feet. Additional skeletal features may include shortened limbs and joint stiffness. The condition belongs to a group of skeletal dysplasias with associated hearing impairment. The epiphyseal abnormalities are visible on radiographic imaging and may show flattened or irregular epiphyses in multiple joints. Progressive joint degeneration can lead to pain and reduced mobility over time. The hearing loss is typically bilateral and may range from moderate to severe. There is currently no cure for this syndrome. Management is supportive and multidisciplinary, involving audiological intervention such as hearing aids or cochlear implants for the hearing loss, orthopedic monitoring and management for skeletal complications, and physical therapy to maintain joint function. Growth hormone therapy may be considered in some cases to address short stature, though its efficacy in this specific condition has not been well established. Regular follow-up with specialists in genetics, audiology, and orthopedics is recommended.

Common questions about Deafness-epiphyseal dysplasia-short stature syndrome